Home  >  Products  >  WBSCR22 (Williams Beuren syndrome chromosome region 22 ) Blocking Peptide (the C terminal of WBSCR22)(100ug)
WBSCR22 (Williams Beuren syndrome chromosome region 22 ) Blocking Peptide (the C terminal of WBSCR22)(100ug)

WBSCR22 (Williams Beuren syndrome chromosome region 22 ) Blocking Peptide (the C terminal of WBSCR22)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-WBSCR22 Antibody (ARP62733_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62733
Size: 100ug
Weight: 32kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a protein containing a nuclear localization signal and an S-adenosyl-L-methionine binding motif typical of methyltransferases, suggesting that the encoded protein may act on DNA methylation. This gene is deleted in Williams syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. Alternatively spliced transcript variants have been found.
Alternative names: HASJ4442; HUSSY-3; MGC19709; MGC2022; MGC5140; PP3381; WBMT